Ca2+ plays a pivotal role in both excitation contraction-coupling (ECC) and activation of signaling pathways in the myocardium. However, it remains a mystery how Ca2+-dependent signaling pathways are activated in myocytes given the overwhelming cytosolic Ca2+ concentrations that are achieved to mediate contraction. One possibility is that specialized pools of Ca2+ have evolved that are spatially distinct from the cytoplasmic Ca2+ transient thereby generating a restricted signaling microdomain. Another possibility that will explored here is that global changes in diastolic Ca2+ Is a primary means of driving the cardiac hypertrophic response and ensuing heart failure, such as through calcineurin-NFAT signaling. Moreover, heart failure is often associated with elevations in total intracellular Na+ levels in adult myocytes. This elevation in Na* can secondarily drive Ca2+ elevations through effects on NCX1. Here we will examine the hypothesis that elevations in Na+ can enhance the cardiac hypertrophic response and disease by secondarily enhancing diastolic Ca2+ levels. To examine this hypothesis in Specific Aim#1 we will generate transgenic mice with enhanced Na* influx, while in Specific Aim #2 we will generate and analyze transgenic and gene-targeted that are manipulated for NCX1 and NKA (Na+ /K+ ATPase). When coupled with careful measurements of intracellular Na and Ca2+ , these first 2 aims will determine if and how diastolic Ca2+ programs hypertrophy through calcineurin-NFAT signaling in the heart. Finally, Specific Aim #3 will investigate the role that the mitochondrial permeability transition pore (MPTP) plays in regulating mitochondrial Ca2+ and propensity toward cardiomyopathy.
of this application is rooted in the fundamental issue of how Ca2+ signaling pathways are controlled in the heart, which is of major medical importance considering the centrality that PKCs, CaMKll, and calcineurin play in controlling pathologic remodeling and heart failure. A better understanding of how Ca2+ regulates both contraction and signaling in a contractile cell, such as a cardiac myocyte, could reveal microdomain regulatory mechanisms that control hypertrophy.
|Yuen, Garrick K; Galice, Samuel; Bers, Donald M (2017) Subcellular localization of Na/K-ATPase isoforms in ventricular myocytes. J Mol Cell Cardiol 108:158-169|
|Burel, Sophie; Coyan, Fabien C; Lorenzini, Maxime et al. (2017) C-terminal phosphorylation of NaV1.5 impairs FGF13-dependent regulation of channel inactivation. J Biol Chem 292:17431-17448|
|Kanaporis, Giedrius; Blatter, Lothar A (2017) Membrane potential determines calcium alternans through modulation of SR Ca2+ load and L-type Ca2+ current. J Mol Cell Cardiol 105:49-58|
|Bovo, Elisa; Huke, Sabine; Blatter, Lothar A et al. (2017) The effect of PKA-mediated phosphorylation of ryanodine receptor on SR Ca2+ leak in ventricular myocytes. J Mol Cell Cardiol 104:9-16|
|Bers, Donald M (2017) CALMing Down Arrhythmogenic Calmodulinopathies via a Precision Medicine Approach. Circ Res 120:3-4|
|Lang, Di; Sato, Daisuke; Jiang, Yanyan et al. (2017) Calcium-Dependent Arrhythmogenic Foci Created by Weakly Coupled Myocytes in the Failing Heart. Circ Res 121:1379-1391|
|Ma, Xiaolong; Chen, Chao; Veevers, Jennifer et al. (2017) CRISPR/Cas9-mediated gene manipulation to create single-amino-acid-substituted and floxed mice with a cloning-free method. Sci Rep 7:42244|
|Dewenter, Matthias; Neef, Stefan; Vettel, Christiane et al. (2017) Calcium/Calmodulin-Dependent Protein Kinase II Activity Persists During Chronic ?-Adrenoceptor Blockade in Experimental and Human Heart Failure. Circ Heart Fail 10:e003840|
|Pereira, Laëtitia; Bare, Dan J; Galice, Samuel et al. (2017) ?-Adrenergic induced SR Ca2+ leak is mediated by an Epac-NOS pathway. J Mol Cell Cardiol 108:8-16|
|Blatter, Lothar A (2017) The intricacies of atrial calcium cycling during excitation-contraction coupling. J Gen Physiol 149:857-865|
Showing the most recent 10 out of 228 publications